DK3533393T3 - Brug af elektroretinografi (erg) til vurdering af psykiatriske lidelser - Google Patents

Brug af elektroretinografi (erg) til vurdering af psykiatriske lidelser Download PDF

Info

Publication number
DK3533393T3
DK3533393T3 DK19166255.0T DK19166255T DK3533393T3 DK 3533393 T3 DK3533393 T3 DK 3533393T3 DK 19166255 T DK19166255 T DK 19166255T DK 3533393 T3 DK3533393 T3 DK 3533393T3
Authority
DK
Denmark
Prior art keywords
electroretinography
erg
assessment
psychiatric disorders
psychiatric
Prior art date
Application number
DK19166255.0T
Other languages
English (en)
Inventor
Marc Hébert
Michel Maziade
Chantal Mérette
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Laval filed Critical Univ Laval
Application granted granted Critical
Publication of DK3533393T3 publication Critical patent/DK3533393T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/398—Electrooculography [EOG], e.g. detecting nystagmus; Electroretinography [ERG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/163—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state by tracking eye movement, gaze, or pupil change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/167—Personality evaluation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Educational Technology (AREA)
  • Social Psychology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK19166255.0T 2013-03-14 2014-03-13 Brug af elektroretinografi (erg) til vurdering af psykiatriske lidelser DK3533393T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361781520P 2013-03-14 2013-03-14
EP14765466.9A EP2956056B1 (en) 2013-03-14 2014-03-13 Electroretinography (erg) system for the assessment of psychiatric disorders

Publications (1)

Publication Number Publication Date
DK3533393T3 true DK3533393T3 (da) 2020-10-19

Family

ID=51535712

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19166255.0T DK3533393T3 (da) 2013-03-14 2014-03-13 Brug af elektroretinografi (erg) til vurdering af psykiatriske lidelser
DK14765466.9T DK2956056T3 (da) 2013-03-14 2014-03-13 Elektroretinografisystem (erg) til vurdering af psykiatriske lidelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14765466.9T DK2956056T3 (da) 2013-03-14 2014-03-13 Elektroretinografisystem (erg) til vurdering af psykiatriske lidelser

Country Status (9)

Country Link
US (3) US20160029919A1 (da)
EP (3) EP3747358B1 (da)
CA (3) CA3126082A1 (da)
DK (2) DK3533393T3 (da)
ES (2) ES2826871T3 (da)
HU (2) HUE052342T2 (da)
PL (2) PL2956056T3 (da)
PT (2) PT3533393T (da)
WO (1) WO2014138987A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3126082A1 (en) 2013-03-14 2014-09-18 Universite Laval Use of electroretinography (erg) for the assessment of psychiatric disorders
US20150105689A1 (en) * 2013-10-10 2015-04-16 Robert F. Miller Pattern electroretinography for evaluating a neurological condition
WO2016118578A1 (en) * 2015-01-20 2016-07-28 Northwestern University Systems and methods to derive models to evaluate behavior outcomes based on brain responses to complex sounds
JP6406171B2 (ja) * 2015-08-25 2018-10-17 トヨタ自動車株式会社 瞬目検知装置
US10588536B2 (en) 2016-02-04 2020-03-17 Northwestern University Methods and systems for identifying non-penetrating brain injuries
US11594310B1 (en) * 2016-03-31 2023-02-28 OM1, Inc. Health care information system providing additional data fields in patient data
US11257574B1 (en) 2017-03-21 2022-02-22 OM1, lnc. Information system providing explanation of models
JP6927491B2 (ja) * 2017-09-12 2021-09-01 東洋紡株式会社 精神神経状態を判別する指標の作成方法および作成装置
JP6865438B2 (ja) * 2017-09-12 2021-04-28 東洋紡株式会社 精神神経状態を判別する指標の作成方法および作成装置
JP6927492B2 (ja) * 2017-09-12 2021-09-01 東洋紡株式会社 睡眠障害を判別する指標の作成方法および作成装置
US11967428B1 (en) * 2018-04-17 2024-04-23 OM1, Inc. Applying predictive models to data representing a history of events
US11862346B1 (en) 2018-12-22 2024-01-02 OM1, Inc. Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions
KR102439639B1 (ko) * 2020-03-24 2022-09-02 비웨이브 주식회사 주요 우울증에 대한 정보 제공 방법 및 이를 이용한 주요 우울증에 대한 정보 제공용 디바이스
JP7830341B2 (ja) * 2020-03-26 2026-03-16 ディアメンティス・インコーポレイテッド 網膜信号データを処理し、状態を識別するためのシステムおよび方法
BR112022024871A2 (pt) * 2020-06-12 2023-11-28 Diamentis Inc Sistemas e métodos para coletar dados de sinal da retina e processo para remover artefatos
JP2025507352A (ja) 2022-02-09 2025-03-18 ディアメンティス・インコーポレイテッド 網膜刺激および／または網膜信号データの収集のためのシステムと方法
WO2026015852A1 (en) * 2024-07-11 2026-01-15 Baylor College Of Medicine A method for using neural activity to assess clinical response after deep brain stimulation for psychiatric disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141245C1 (ru) * 1998-11-03 1999-11-20 Городская многопрофильная больница N 2, г.Санкт-Петербурга Способ определения тактики нейрохирургического вмешательства при хронической сосудисто-мозговой недостаточности
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
AU785226B2 (en) 2001-09-25 2006-11-16 United States Department Of Veterans Affairs Method and apparatus for diagnosing schizophrenia and schizophrenia subtype
US7670764B2 (en) 2003-10-24 2010-03-02 Prometheus Laboratories Inc. Methods of diagnosing tissue fibrosis
US7575321B2 (en) * 2003-10-30 2009-08-18 Welch Allyn, Inc. Apparatus and method of diagnosis of optically identifiable ophthalmic conditions
US9913976B2 (en) 2006-06-19 2018-03-13 Highland Instruments, Inc. Systems and methods for stimulating and monitoring biological tissue
US9623241B2 (en) 2006-06-19 2017-04-18 Highland Instruments Treatment methods
US7959578B2 (en) 2008-02-01 2011-06-14 Lonky Martin L Methods and techniques to measure, map and correlate ocular micro-movement and ocular micro-tremor (OMT) signals with cognitive processing capabilities in ADD/ADHD individuals
WO2009128903A2 (en) * 2008-04-15 2009-10-22 The United States Of America, As Represented By The Secretary Of Agriculture Method to detect transmissible spongiform encephalopathies via electroretinogram
EP2315833B8 (en) 2008-05-20 2015-05-27 Eos Neuroscience, Inc. Vectors for delivery of light-sensitive proteins and methods of use
US20100204325A1 (en) 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
ES2574136T5 (es) 2009-04-17 2019-08-30 Natac Pharma S L Composiciones ricas en ácidos grasos omega 3 con un bajo contenido en ácido fitánico
US20130137728A1 (en) 2010-03-24 2013-05-30 MUSC Foundation for Research and Development Compositions and Methods for the Treatment of Degenerative Diseases
EP3567106A1 (en) 2010-04-23 2019-11-13 University of Massachusetts Cns targeting aav vectors and methods of use thereof
CN104474546A (zh) 2010-08-13 2015-04-01 弗·哈夫曼-拉罗切有限公司 用于疾病治疗的针对IL-1β和IL-18的抗体
US20140099284A1 (en) 2010-10-15 2014-04-10 Eos Neuroscience, Inc Modulation neural pathways
WO2012116334A2 (en) * 2011-02-24 2012-08-30 Patient Tools, Inc. Methods and systems for assessing latent traits using probabilistic scoring
CA3126082A1 (en) 2013-03-14 2014-09-18 Universite Laval Use of electroretinography (erg) for the assessment of psychiatric disorders
US20150105689A1 (en) * 2013-10-10 2015-04-16 Robert F. Miller Pattern electroretinography for evaluating a neurological condition

Also Published As

Publication number Publication date
EP2956056A4 (en) 2016-11-02
PL2956056T3 (pl) 2020-01-31
US20220133209A1 (en) 2022-05-05
HK1219037A1 (en) 2017-03-24
US12357223B2 (en) 2025-07-15
HUE052342T2 (hu) 2021-04-28
ES2744833T3 (es) 2020-02-26
ES2826871T3 (es) 2021-05-19
PL3533393T3 (pl) 2021-01-25
CA3126082A1 (en) 2014-09-18
US20200085338A1 (en) 2020-03-19
CA3060726A1 (en) 2014-09-18
CA3060726C (en) 2021-09-14
CA2905202C (en) 2019-12-31
PT3533393T (pt) 2020-11-04
EP2956056B1 (en) 2019-06-05
EP2956056A1 (en) 2015-12-23
EP3747358B1 (en) 2025-10-15
EP3533393B1 (en) 2020-07-22
US11259738B2 (en) 2022-03-01
PT2956056T (pt) 2019-09-20
CA2905202A1 (en) 2014-09-18
DK2956056T3 (da) 2019-09-16
EP3747358A3 (en) 2021-03-10
EP3533393A1 (en) 2019-09-04
HUE044954T2 (hu) 2019-11-28
EP3747358A2 (en) 2020-12-09
EP3747358C0 (en) 2025-10-15
WO2014138987A1 (en) 2014-09-18
US20160029919A1 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
DK2956056T3 (da) Elektroretinografisystem (erg) til vurdering af psykiatriske lidelser
LT3728870T (lt) Plokščių rinkinys
DK3663282T3 (da) Pyrrolidinonherbicider
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
HRP20180900T1 (hr) Heterociklički amidi kao inhibitori kinaza
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
HUE042443T2 (hu) GPR6 tetrahidropiridopirazin-modulátorai
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3137456T3 (da) Pyridazinonherbicider
EP3471806A4 (en) USER RECORDING DEVICE.
DK2965026T3 (da) Generering af slushice
DK2956071T3 (da) Sæt til perifer nerveblokering
DK3007726T3 (da) Fremgangsmåder til behandling af en tauopati
DK2984480T3 (da) Fremgangsmåde til bestemmelse af filmdannende aminer
EP3006444A4 (en) HETEROCYCLIC AMID COMPOUND
DK3230255T3 (da) Regulatorer af uhæmmet adfærd
BR112016010568A2 (pt) hidrogenação catalítica de nitrilas
EP3515494A4 (en) REGULATORS OF B-LYMPHOCYTES MEDIA IMMUNOSUPPRESSION
CL2016000616A1 (es) Compuestos heterocíclicos de n-acilimino.
DK3019662T3 (da) Diffraktionsanordning til diffraktion af lyd
SMT201800593T1 (it) Inibitore per disturbi retinocoroidei
DK2854141T3 (da) Overspændingsafleder
CL2016001118A1 (es) Compuestos heterocíclicos de n-acilimino
EP3544021A4 (en) Thermonuclear reactor
UA29879S (uk) Комплект монтажних пластин для лижного кріплення